- Home
- AVIR vs GPRK Comparison
AVIR vs GPRK Comparison
Compare AVIR & GPRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- GPRK
- Stock Information
- Founded
- AVIR 2012
- GPRK 2002
- Country
- AVIR United States
- GPRK Colombia
- Employees
- AVIR N/A
- GPRK N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- GPRK Oil & Gas Production
- Sector
- AVIR Health Care
- GPRK Energy
- Exchange
- AVIR Nasdaq
- GPRK Nasdaq
- Market Cap
- AVIR 290.4M
- GPRK 335.7M
- IPO Year
- AVIR 2020
- GPRK N/A
- Fundamental
- Price
- AVIR $3.27
- GPRK $8.09
- Analyst Decision
- AVIR Hold
- GPRK Buy
- Analyst Count
- AVIR 1
- GPRK 1
- Target Price
- AVIR $6.00
- GPRK $11.00
- AVG Volume (30 Days)
- AVIR 453.6K
- GPRK 1.7M
- Earning Date
- AVIR 11-07-2025
- GPRK 11-05-2025
- Dividend Yield
- AVIR N/A
- GPRK 7.16%
- EPS Growth
- AVIR N/A
- GPRK N/A
- EPS
- AVIR N/A
- GPRK 0.81
- Revenue
- AVIR N/A
- GPRK $560,354,000.00
- Revenue This Year
- AVIR N/A
- GPRK N/A
- Revenue Next Year
- AVIR N/A
- GPRK N/A
- P/E Ratio
- AVIR N/A
- GPRK $8.19
- Revenue Growth
- AVIR N/A
- GPRK N/A
- 52 Week Low
- AVIR $2.46
- GPRK $5.66
- 52 Week High
- AVIR $4.02
- GPRK $11.72
- Technical
- Relative Strength Index (RSI)
- AVIR 57.88
- GPRK 67.81
- Support Level
- AVIR $3.15
- GPRK $6.52
- Resistance Level
- AVIR $3.34
- GPRK $8.27
- Average True Range (ATR)
- AVIR 0.10
- GPRK 0.32
- MACD
- AVIR 0.02
- GPRK 0.18
- Stochastic Oscillator
- AVIR 79.37
- GPRK 92.86
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.